Tempest Therapeutics Shares Resumed Trade
Portfolio Pulse from Benzinga Newsdesk
Trading of Tempest Therapeutics shares has resumed.
October 13, 2023 | 4:39 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Trading of Tempest Therapeutics shares has resumed, which may affect the stock's price.
The resumption of trading can lead to increased volatility in the stock's price. Depending on the reason for the halt, the stock could either rise or fall. However, without specific information on the reason for the halt, it's difficult to predict the direction.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100